TherapeuticsMD, Inc. (TXMD)
NASDAQ: TXMD · Real-Time Price · USD
1.480
-0.040 (-2.63%)
May 14, 2025, 12:48 PM - Market open

TherapeuticsMD Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
-2.1-2.18-10.28112-172.42-183.52
Upgrade
Depreciation & Amortization
0.470.510.441.190.744.07
Upgrade
Other Amortization
-----2.53
Upgrade
Asset Writedown & Restructuring Costs
1.361.270.48--1.13
Upgrade
Stock-Based Compensation
0.180.261.2711.5718.1310.68
Upgrade
Provision & Write-off of Bad Debts
-----0.24
Upgrade
Other Operating Activities
-0.29-0.352.45-111.3293.838.75
Upgrade
Change in Accounts Receivable
------8.22
Upgrade
Change in Inventory
------3.34
Upgrade
Change in Accounts Payable
0.040.23-2.14-1.21-1.061.89
Upgrade
Change in Other Net Operating Assets
2.451.43-15.31-2.885.656.33
Upgrade
Operating Cash Flow
1.410.73-48.14-4.08-142.69-159.47
Upgrade
Capital Expenditures
-----0.03-0.21
Upgrade
Sale (Purchase) of Intangibles
----0.36-2.19-1.39
Upgrade
Other Investing Activities
---223.83--
Upgrade
Investing Cash Flow
---223.48-2.22-1.6
Upgrade
Long-Term Debt Issued
-----50
Upgrade
Long-Term Debt Repaid
----219.43-50-
Upgrade
Net Debt Issued (Repaid)
----219.43-5050
Upgrade
Issuance of Common Stock
--3.152.47184.6731.98
Upgrade
Other Financing Activities
----1.27-5.12-1.25
Upgrade
Financing Cash Flow
--3.15-235.21129.5580.73
Upgrade
Net Cash Flow
1.410.73-44.99-15.81-15.36-80.34
Upgrade
Free Cash Flow
1.410.73-48.14-4.08-142.73-159.68
Upgrade
Free Cash Flow Margin
76.43%41.57%-3697.46%-5.83%-5547.10%-246.14%
Upgrade
Free Cash Flow Per Share
0.120.06-4.61-0.43-17.93-28.96
Upgrade
Cash Interest Paid
---13.5525.0725.85
Upgrade
Levered Free Cash Flow
-1.05-2.99-33.8738.54-28.46-93.54
Upgrade
Unlevered Free Cash Flow
-1.05-2.99-33.8738.54-28.46-78.21
Upgrade
Change in Net Working Capital
-0.171.5830.25-19.470.37-5.15
Upgrade
Updated Nov 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q